chr2-96123911-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002036.4(ASTL):c.1235G>A(p.Ser412Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,028 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002036.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASTL | NM_001002036.4 | c.1235G>A | p.Ser412Asn | missense_variant | 9/9 | ENST00000342380.3 | NP_001002036.3 | |
ASTL | XM_011511205.3 | c.1250G>A | p.Ser417Asn | missense_variant | 8/8 | XP_011509507.1 | ||
ASTL | XM_011511207.3 | c.1196G>A | p.Ser399Asn | missense_variant | 8/8 | XP_011509509.1 | ||
ASTL | XM_011511208.3 | c.*336G>A | 3_prime_UTR_variant | 7/7 | XP_011509510.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASTL | ENST00000342380.3 | c.1235G>A | p.Ser412Asn | missense_variant | 9/9 | 1 | NM_001002036.4 | ENSP00000343674 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251278Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135834
GnomAD4 exome AF: 0.0000582 AC: 85AN: 1461694Hom.: 1 Cov.: 31 AF XY: 0.0000701 AC XY: 51AN XY: 727162
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.1235G>A (p.S412N) alteration is located in exon 9 (coding exon 9) of the ASTL gene. This alteration results from a G to A substitution at nucleotide position 1235, causing the serine (S) at amino acid position 412 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at